Cite Filings / PHAT / 0000950170-23-012750

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Phathom Pharmaceuticals, Inc. Filed 2023-04-13 Acc 0000950170-23-012750

Documents 1

DEFA14A Proxy Materials , phat-defa14a-2023_notice.htm

Around this filing

2024-04-12 DEFA14A Proxy Materials
2023-04-13 DEFA14A Proxy Materials
2023-04-13 DEF 14A Proxy Statement
2023-04-13 ARS Annual Report to Security Holders
2023-04-11 4 Director bought 1,000 shares at $7.55 ($7,550)
2023-04-11 4 Chief Operating Officer bought 10,000 shares at $8.26 ($82,600)
2022-04-26 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading phat-defa14a-2023_notice.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…